Michigan Department of Health and Human Services, Detroit, MI.
From the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Sex Transm Dis. 2021 Dec 1;48(12):e228-e235. doi: 10.1097/OLQ.0000000000001491.
Since 2010, reported chlamydia and gonorrhea rates decreased among Black women aged 15 to 19 years and were stable for Black women aged 20 to 24 years in the United States. Rates increased for older Black women aged 25 to 39 years and all White women. The Black/White rate ratio decreased across age groups. We examined whether trends in reported rates reflected changing prevalence or changing screening. We analyzed trends in reported chlamydia and gonorrhea rates from 2010 to 2018 among women in the United States aged 15 to 39 years by age and race/ethnicity subgroup, state, and reporting source. Most jurisdictions reported decreased chlamydia and gonorrhea rates among Black teens and increased rates among White teens and older women. Between 2010 and 2018, public clinics reported fewer cases, especially among young Black women, that were not restored by increases elsewhere. We reviewed literature on trends in screening, prevalence, and sequelae. Family planning clinics annual reports showed chlamydia tests among women younger than 25 years decreased by 541,573 tests (-38%) in 2018 compared with 2010 and the number of women visiting sexually transmitted disease clinics had decreased 50% by 2016 compared with 2010. Prevalence of chlamydia in a sentinel population (Job Corps) was unchanged for Black women younger than 25 years and increased for Whites aged 20 to 24 years. Sequelae trends using data from a large all-payer emergency department database were mixed: pelvic inflammatory disease decreased, whereas ectopic pregnancy increased. Decreases in testing at public clinics likely missed diagnoses among young Black women, a group traditionally at highest risk and in need of more testing. Innovative approaches to screening are needed.
自 2010 年以来,美国 15 至 19 岁的黑人女性和 20 至 24 岁的黑人女性的衣原体和淋病报告率下降,而 25 至 39 岁的老年黑人女性和所有白人女性的报告率上升。各年龄段的黑/白比率都有所下降。我们研究了报告率的变化趋势是否反映了流行率的变化或筛查率的变化。我们分析了 2010 年至 2018 年间美国 15 至 39 岁的女性中按年龄和种族/族裔分组、州和报告来源报告的衣原体和淋病的报告率的变化趋势。大多数管辖区报告说,黑人青少年的衣原体和淋病报告率下降,而白人青少年和老年女性的报告率上升。在 2010 年至 2018 年期间,公共诊所报告的病例减少,尤其是年轻的黑人女性,而其他地方的病例增加并没有弥补这些减少。我们回顾了关于筛查、流行率和后遗症趋势的文献。计划生育诊所的年度报告显示,2018 年,25 岁以下女性的衣原体检测量比 2010 年减少了 541,573 次(减少 38%),而到 2016 年,到性传播疾病诊所就诊的女性人数比 2010 年减少了 50%。在一个哨点人群(职业培训生)中,25 岁以下的黑人女性的衣原体流行率保持不变,而 20 至 24 岁的白人女性的流行率上升。使用来自大型所有支付者急诊数据库的数据的后遗症趋势喜忧参半:盆腔炎减少,而宫外孕增加。公共诊所检测量的减少可能导致年轻黑人女性的诊断漏诊,这一群体历来风险最高,需要更多的检测。需要创新的筛查方法。